ABSTRACT The pharmacokinetics of progesterone (dose: 10 jig per animal) were studied in blood and cerebrospinal fluid of adult ovariectomized rhesus monkeys after the administration of the steroid as an intravenous injection, intravenous infusion (duration of infusion: 10 min), or nasal spray. The bioavailability of progesterone, in terms of area under the time-concentration curve and the maximal concentration in the two body fluids, was significantly higher when the steroid was infused or sprayed intranasally than when it was injected intravenously. The clearance of the steroid from the serum, as estimated by its elimination rate constant, elimination half-life, and total body clearance, did not differ for the three methods ofadministration. These findings suggest that the bioavailability of progesterone is enhanced by extending the duration over which the steroid is delivered into the hemal circulation.
Reports from our laboratories have shown that marked neuroendocrine effects leading to an impairment of ovarian (1) or testicular (2) functions occur after the intranasal spraying ofprogesterone in extremely low doses likely to be ineffective when administered by oral or systemic routes. It has been suggested (3) that these marked effects observed with low doses of the steroid administered by an unconventional route may be related to the rapid and preferential transfer of the steroid to the brain via the cerebrospinal fluid (CSF). This suggestion is based on the finding of much higher levels of progesterone in the CSF after its being sprayed intranasally in comparison with its systemic administration (4, 5) .
Because the pharmacological effects of a drug are known to be related to its bioavailability to target tissues rather than to its administered dose, it was felt that a comparison of the pharmacokinetics of progesterone after its systemic administration and intranasal spraying would be useful in furthering our understanding of these unique, low-dose effects occurring upon administering the steroid by an unconventional method. The studies reported here were carried out to obtain such data with particular reference to the bioavailability ofprogesterone to tissues bathed by blood, CSF, or both after the administration of progesterone by three different methods: intravenous (i.v.) injection, i.v. infusion, and nasal spray (n.s.).
MATERIALS AND METHODS Animals. Six healthy adult female rhesus monkeys of similar body weights (5-6.5 kg) and sizes (6) were selected from the Primate Research Facility of our institute (7) . These animals consistently exhibited ovulatory menstrual cycles ofnormal duration (23-28 days) before they were ovariectomized. They were used 2 months after ovariectomy. The clinical condition of all the animals, with particular reference to their liver and renal functions, as evaluated by estimating blood or serum levels of proteins, albumin, bilirubin, alkaline phosphatase, glutamic-oxaloacetic transaminase, glutamic-pyruvic transaminase, urea, and creatinine were within normal values reported for this species (8) . The (3, 10) . The antecubital vein was used for the systemic administration of the steroid, and blood samples were drawn from the saphenous vein. Samples of clear free-flowing CSF were drawn from the cisterna magna as described (11) .
All six of the animals were subjected to the three methods of progesterone administration in sequence ( Table 1) . The animals were anesthetized before progesterone was administered and they remained anesthetized throughout the period of sampling the body fluids. The animals were rested for 2 weeks between experiments and their diet was supplemented with hematinics.
Estimation of Progesterone. Progesterone was estimated in the two body fluids by specific radioimmunoassay as described (12, 13) . The coefficients ofvariation within and between assays were, respectively, 7.12 ± 1.26% and 9.45 ± 1.04%.
Pharmacokinetic Parameters. A two-compartment kinetic model with first-order absorption and clearance (14) was assumed to determine the following parameters (15 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. culated by using the trapezoidal rule (16) according to the following formula (17):
in which n is the number of experimental points, y(i) is the ith serum/CSF sample, and t(i) is time of the ith sample. AUC for serum and CSF was calculated between 0 and 60 min. The AUC for serum between 0 and X0 min was calculated by using the formula AUC =AUCG +-6 in which C60 is the concentration ofprogesterone at 60 min and Elimination rate constant ((3). 3 was determined by linear regression analysis of the serum decay curve after the i.v. injection. The last three data points in 15, 30, and 60 min showed a linear decline and hence these points were taken for calculating (3.
Elimination half-life (t1,2(3). This was calculated by using the relationship 0.693
Apparent volume ofdistribution (V, (Table 6 ).
DISCUSSION
The pharmacokinetics of endogenously produced progesterone have been extensively investigated and reviewed (19) (20) (21) , but comparable data for exogenously administered progesterone are not available. The present study has thrown some light on the pharmacokinetics ofprogesterone after its systemic administration. Besides providing such information, the present studies have shown that the detectable levels ofprogesterone in serum (18) . NS, not significant; *, P < 0.05; **, P < 0.01. (18) . NS, not significant; *, P < 0.05; **, P < 0.01. and CSF as well as its bioavailability in terms ofAUC and Cm,, in both the body fluids differ markedly depending on the method of administering the compound.
The AUC and Cm, of progesterone in the two body fluids were significantly enhanced when the steroid was delivered over an extended period oftime as an i.v. infusion in comparison with a comparable dose being almost instantaneously delivered as a bolus into the systemic circulation 'by i.v. injection. 'Interestingly, the clearance of the steroid from serum as estimated by determining 1, t112(, and C1TB did not differ significantly between i.v. injection and i.v. infusion. These findings suggest that the enhancement in the levels of progesterone as well as the amplification ofits bioavailability in the body fluids may be related to the duration over which the steroid enters the blood circulation rather than to differences in its clearance rates among different methods of its administration. More studies are, however, necessary to define in precise mathematical terms the relationship between the duration of administering into the systemic circulation and the amplification ofits bioavailability.
The values obtained for the concentrations of progesterone and .its bioavailability in the body fluids after the intranasal spraying of the compound-were significantly higher than those observed after i.v. injection. Though the values obtained after n.s. were lower than those obtained after i.v. infusion, these values were not significantly different. It must, however, be noted that the actual amount of the steroid deposited into the nasal cavity was much less than that administered by the systemic routes.
Because progesterone sprayed into the nostrils would be deposited onto the nasal mucosa the question arises as to how can such "topically".administered steroid show bioavailability values that are much higher than the values observed after its direct injection into the venous blood. Studies -involving radionuchde imaging techniques have shown that most of the substances sprayed into the nostrils are deposited on the olfactory mucosa (10) . Electron microscopic studies ofcolloidal gold particles sprayed onto the olfactory mucosa have shown that these particles are pinocytosed by both the olfactory dendrites and the adjoining supporting cells of the olfactory epithelium. Substances entering each ofthese two cell types are transported separately to different destinations. Particles entering the ol- (10) . These morphological studies have traced the pathways by which particulate materials are transported into the body fluids across the olfactory mucosa, but the question as to whether lipophilic substances, such as progesterone in solution, also enter the olfactory mucosa by pinocytosis or-by simple diffusion needs to be determined.
Be that as it may, progesterone entering the olfactory mucosa by pinocytosis or by simple diffusion will enter the body fluids at a much slower rate than progesterone injected as a bolus directly into the systemic circulation. It is therefore not surprising that the levels and bioavailability ofprogesterone in the body fluids after its being administered by n.s. is greater than those observed after i.v. injection, as has been observed when the steroid is infused over an extended period of time.
Thus, the present studies have shown that the concentrations of progesterone and its bioavailability differ markedly with different methods of administration. These studies also offer an explanation for the marked pharmacological effects observed after the intranasal spraying of extremely low doses of progesterone (22, 23) . The present studies also indicate the possibility of administering physiological doses of progesterone as nasal sprays for replacement therapy or contraceptive purposes.
